151 related articles for article (PubMed ID: 12671842)
21. [Subjective general assessment of nutritional status in patients with chronic renal failure and regular hemodialysis].
Jerin L; Ladavac R; Kuzmanović G; Dodić D; Griparić D
Acta Med Croatica; 2003; 57(1):23-8. PubMed ID: 12876858
[TBL] [Abstract][Full Text] [Related]
22. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis.
Cengiz N; Baskin E; Agras PI; Sezgin N; Saatci U
Transplant Proc; 2005 Sep; 37(7):2915-7. PubMed ID: 16213260
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of C-reactive protein for heart disease in dialysis patients.
Wang AY
Curr Opin Investig Drugs; 2005 Sep; 6(9):879-86. PubMed ID: 16187687
[TBL] [Abstract][Full Text] [Related]
24. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
Wanner C; Zimmermann J; Quaschning T; Galle J
Kidney Int Suppl; 1997 Nov; 62():S53-5. PubMed ID: 9350681
[TBL] [Abstract][Full Text] [Related]
25. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
[TBL] [Abstract][Full Text] [Related]
27. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship?
Dervisoglu E; Eraldemir C; Kalender B; Kir HM; Caglayan C
J Ren Nutr; 2008 Jul; 18(4):332-7. PubMed ID: 18558297
[TBL] [Abstract][Full Text] [Related]
28. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
[TBL] [Abstract][Full Text] [Related]
29. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
30. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
31. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
32. Biochemistry and biomarkers of inflamed patients: why look, what to assess.
Kaysen GA
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S56-63. PubMed ID: 19996007
[TBL] [Abstract][Full Text] [Related]
33. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
34. Do inflammatory markers add predictive information of death beyond that provided by age and comorbidity in chronic renal failure patients?
Caravaca F; Martín MV; Barroso S; Ruiz B; Hernández-Gallego R
Nephrol Dial Transplant; 2006 Jun; 21(6):1575-81. PubMed ID: 16484235
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
J Intern Med; 2007 Dec; 262(6):690-701. PubMed ID: 17908160
[TBL] [Abstract][Full Text] [Related]
36. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.
Lin-Tan DT; Lin JL; Wang LH; Wang LM; Huang LM; Liu L; Huang JY; Huang YL
J Am Soc Nephrol; 2007 Aug; 18(8):2385-91. PubMed ID: 17599971
[TBL] [Abstract][Full Text] [Related]
37. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
[TBL] [Abstract][Full Text] [Related]
38. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
39. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
[TBL] [Abstract][Full Text] [Related]
40. [Hypoalbuminemia in dialysis. Is it a marker for malnutrition or inflammation?].
Cueto Manzano AM
Rev Invest Clin; 2001; 53(2):152-8. PubMed ID: 11421111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
